{
    "medicine_id": "5887ab9c71de3ff2eed0ca93bfdf075f7c0009b3",
    "platform_id": "DB14723",
    "metadata": {
        "name": "Vitrakvi 25 mg 1 Capsule",
        "composition": "25 mg 1 Larotrectinib",
        "clinical_particulars": {
            "therapeutic_indications": "Larotrectinib is a tyrosine kinase inhibitor that is currently indicated for the treatment of adult and pediatric patients with solid tumors that either a have a neurotrophic receptor tyrosine kinase NTRK gene fusion without a known acquired resistance mutation b are metastatic or where surgical resection is likely to result in severe morbidity and c have no satisfactory alternative treatments or that have progressed following treatment FDA Label At the moment these uses of larotrectinib are only approved under the auspices of an accelerated approval by the US FDA based on overall response rate and duration of response and continuation of support for these indications may be contingent upon the verification and description of continued clinical benefit in confirmatory trials FDA Label",
            "contraindications": {
                "disease": "Although there is no available data on larotrectinib use in pregnant women based on literature reports in human subjects with congenital mutations leading to changes in TRK signaling findings from animal studies and the agent s mechanism of action it is believed that larotrectinib can cause embryo fetal harm when administered to a pregnant woman FDA Label Published reports of individuals with congenital mutations in TRK pathway proteins suggest that decreases in TRK mediated signaling are correlated with obesity developmental delays cognitive impairment insensitivity to pain and anhidrosis FDA Label Furthermore animal studies data note that lacrotrectinib can cross the placenta in animals FDA Label Advise pregnant women of the potential risk to a fetus FDA Label There are no data on the presence of larotrectinib or its metabolites in human milk and no data on its effects on the breastfed child or on milk production FDA Label Because of the potential for serious adverse reactions in breastfed children advise women not to breastfeed during treatment with larotrectinib and for 1 week after the final dose FDA Label Female patients of reproductive potential who are being treated with larotrectinib are advised to use effective contraception during larotrectinib treatment and for at least one week after the final dose FDA Label Males with female partners of reproductive potential are also advised to use effective contraception during larotrectinib therapy and for one week after the final dose FDA Label Based on histopathological findings in the reproductive tracts of female rats in a 1 month repeated dose study larotrectinib use may reduce fertility in females FDA Label The safety and effectiveness of larotrectinib in pediatric patients was established based upon data from clinical trials in adult or pediatric patients 28 days and older FDA Label The pharmacokinetics of larotrectinib in the pediatric population have also been determined to be similar to those seen in adults FDA Label Clinical studies of larotrectinib did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects FDA Label No dose adjustment is recommended for patients with mild hepatic impairment Child Pugh A Larotrectinib clearance was reduced in subjects with moderate Child Pugh B to severe Child Pugh C hepatic impairment FDA Label No dose adjustment is recommended for patients with renal impairment of any severity FDA Label Carcinogenicity studies have not been conducted with larotrectinib FDA Label Larotrectinib was not mutagenic in the in vitro bacterial reverse mutation Ames assays with or without metabolic activation or in the in vitro mammalian mutagenesis assays with or without metabolic activation FDA Label In vivo larotrectinib was negative in the mouse micronucleus test FDA Label Fertility studies with larotrectinib have not been conducted In a 3 month repeat dose toxicity study in the rat larotrectinib had no effects on spermatogenesis at 75 mg kg day approximately 7 times the human exposure at the 100 mg twice daily dose FDA Label Additionally larotrectinib had no histological effects on the male reproductive tract in rats or monkeys at doses resulting in exposures up to 10 times the human exposure AUC0 24hr at the 100 mg twice daily clinical dose FDA Label In a 1 month repeat dose study in the rat decreased uterine weight and uterine atrophy were seen at 200 mg kg day approximately 45 times the human exposure AUC at the 100 mg twice daily dose FDA Label Fewer corpora lutea and increased incidence of anestrus were also noted at doses 60 mg kg day approximately 10 times the human exposure at the 100 mg twice daily dose FDA Label There were no findings in female reproductive organs in repeat dose studies in monkeys at exposures up to 22 times the human exposure at the 100 mg twice daily dose FDA Label In a 1 month repeat dose study in the rat decreased uterine weight and uterine atrophy were seen at 200 mg kg day approximately 45 times the human exposure AUC at the 100 mg twice daily dose FDA Label Fewer corpora lutea and increased incidence of anestrus were also noted at doses 60 mg kg day approximately 10 times the human exposure at the 100 mg twice daily dose FDA Label Decreased fertility occurred in a juvenile animal study FDA Label There were no findings in female reproductive organs in repeat dose studies in monkeys at exposures up to 22 times the human exposure at the 100 mg twice daily dose FDA Label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "At doses that are nine fold greater than the recommended adult dose larotrectinib does not elicit any QTc interval prolongation that is clinically relevant FDA Label",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The serum concentration of Acetaminophen can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Larotrectinib can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Larotrectinib can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Larotrectinib can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Amiodarone can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Lopinavir can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Larotrectinib can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The serum concentration of Vincristine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The serum concentration of Bortezomib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Imipramine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Trimipramine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Nortriptyline can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Silodosin"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Sofosbuvir"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Technetium Tc 99m sestamibi"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Selexipag"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Grazoprevir"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Vinflunine"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Talazoparib"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Revefenacin"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Duvelisib"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Elagolix"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Omadacycline"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Copanlisib"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Grapiprant"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tenofovir"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Saquinavir can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The serum concentration of Dasatinib can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Enfortumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tazemetostat"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tezacaftor"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Avatrombopag"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lefamulin"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Tenofovir disoproxil"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Darolutamide"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lusutrombopag"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Rimegepant"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Selumetinib"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00066",
                        "description": "The therapeutic efficacy of Follitropin can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The therapeutic efficacy of Carbimazole can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "The therapeutic efficacy of 3 5 Diiodotyrosine can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB05084",
                        "description": "The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06285",
                        "description": "The therapeutic efficacy of Teriparatide can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB09421",
                        "description": "The therapeutic efficacy of Protirelin can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB12629",
                        "description": "The therapeutic efficacy of 3 5 diiodothyropropionic acid can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The therapeutic efficacy of Elcatonin can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB15263",
                        "description": "The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The therapeutic efficacy of Methimazole can be decreased when used in combination with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Larotrectinib can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Tucatinib may decrease the excretion rate of Larotrectinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Larotrectinib can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}